News

The FDA is investigating the risk of heart attack, stroke and death in men using FDA approved prescription testosterone products. A study by the National Cancer Institute and a study published in the Journal of The American Medical Association (JAMA), in November of 2013, prompted the FDA investigation. The studies showed that three months after beginning "low-T" treatments with testosterone therapy drugs, the risk of heart attack doubled among men over 65 and younger men with a history of heart disease.

Testosterone Replacement Therapy Side Effects:

Individual settlement in the amount of $300,000.00 for client injured after using a medication sold by an international pharmaceutical company.

Pendley, Baudin and Coffin, L.L.P. has been the first law firm to file a Lipitor suit in Louisiana; the firm has also filed a suit in South Carolina.

Lipitor, a cholesterol lowering statin medication, and its generic version atorvastatin have been linked to an increased risk for diabetes in women. Studies found that women aged of 50 to 79, who were taking Lipitor or the generic atorvastatin, were at a higher risk of developing Type 2 diabetes. Lipitor is produced and sold by Pfizer a pharmaceutical company.

National settlement exceeding $900 million in multiple class actions involving defective polybutylene pipe.

Class action settlement of $9 million related to chlorinated phenol pollution of Mississippi river by major international chemical company.

The federal court overseeing the BP Oil Spill Litigation in New Orleans approved a settlement to pay claims,  including those of businesses who submit qualifying economic loss claims.  The Gulf Coast Claims Facility (GCCF) has closed its doors and the Deepwater Horizon Economic and Property Damage Settlement Claims Program is processing claims.

Yaz, Yasmin and Ocella (the generic), some of the most popular birth control pills in the United States, are associated with a significantly higher risk of blood clots (deep vein thrombosis), stroke, pulmonary embolism, heart attack and gallbladder disease. Medical reports found that drsp or drospirenone, a progestin contained in the pills, is the cause of these risk.

Stryker Corporation announced the recall of its Rejuvenate Modular and ABG II modular neck hip stems in July of 2012. Stryker warns that fretting and corrosion due to abrasive wear could lead to corrective hip revision surgery. This fretting and corrosion could lead to the following problems: